Last update at 2025-05-16T16:44:00Z
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
Qualcomm downgraded, Wingstop upgraded: Wall Street's top analyst calls
Thu 03 Aug 23, 02:03 PMWeekly Roundup on the Cannabis Sector & Psychedelic Sector
Mon 08 Aug 22, 11:00 AMCannabis Industry Investor Conference Presentations Now Available for On-Demand Viewing
Wed 08 Jun 22, 12:35 PMCannabis Industry Investor Conference: Company Executives Present June 7th
Fri 03 Jun 22, 12:35 PMTSX Venture Exchange Stock Maintenance Bulletins
Sat 13 Feb 21, 06:25 AMBreakdown | 2022-10-31 | 2021-10-31 | 2020-10-31 | 2019-10-31 | 2018-10-31 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2022-10-31 | 2021-10-31 | 2020-10-31 | 2019-10-31 | 2018-10-31 |
Income before tax | -73.76300M | -35.76700M | -6.12500M | -27.00000M | -6.02755M |
Minority interest | -0.90800M | -0.68000M | 1.55M | -0.17900M | -0.01300M |
Net income | -71.75600M | -35.71700M | -6.35400M | -26.12600M | -4.53255M |
Selling general administrative | 90.90M | 54.27M | 22.64M | 29.46M | 6.62M |
Selling and marketing expenses | - | - | - | - | - |
Gross profit | 100.95M | 63.98M | 30.81M | 11.32M | 3.11M |
Reconciled depreciation | 30.17M | 23.57M | 6.80M | 1.40M | 0.09M |
Ebit | -20.11300M | -13.85000M | 1.37M | -19.51200M | -4.30700M |
Ebitda | -33.64600M | -1.96100M | 8.67M | -23.76800M | -5.79419M |
Depreciation and amortization | - | - | - | - | - |
Non operating income net other | - | - | - | - | - |
Operating income | -20.11300M | -13.85000M | 1.37M | -19.55000M | -3.59393M |
Other operating expenses | - | - | 0.04M | 0.04M | 0.47M |
Interest expense | 9.95M | 10.24M | 8.00M | 1.83M | 0.15M |
Tax provision | -2.91500M | -0.73000M | 0.23M | -0.70800M | -1.49500M |
Interest income | - | 0.00000M | 0.13M | - | - |
Net interest income | -9.94800M | -15.13300M | -9.90800M | -3.41300M | -0.14754M |
Extraordinary items | - | - | - | - | - |
Non recurring | - | - | - | - | - |
Other items | - | - | - | - | - |
Income tax expense | -2.91500M | -0.73000M | 0.23M | -0.70800M | -1.49600M |
Total revenue | 356.85M | 181.12M | 83.27M | 31.29M | 8.75M |
Total operating expenses | 376.96M | 194.97M | 81.89M | 50.84M | 12.34M |
Cost of revenue | 255.90M | 117.14M | 52.45M | 19.98M | 5.64M |
Total other income expense net | -43.70200M | -6.78400M | 2.41M | -4.03700M | -2.28608M |
Discontinued operations | - | - | - | - | - |
Net income from continuing ops | -70.84800M | -35.03700M | -6.35400M | -26.29200M | -4.53255M |
Net income applicable to common shares | -71.75600M | -34.35700M | -6.35400M | -26.29200M | -4.53300M |
Preferred stock and other adjustments | - | - | - | - | - |
Breakdown | 2023-10-31 | 2022-10-31 | 2021-10-31 | 2020-10-31 | 2019-10-31 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2023-10-31 | 2022-10-31 | 2021-10-31 | 2020-10-31 | 2019-10-31 |
Total assets | 233.40M | 274.74M | 246.22M | 69.81M | 40.74M |
Intangible assets | 27.28M | 62.07M | 62.33M | 11.96M | 8.04M |
Earning assets | - | - | - | - | - |
Other current assets | - | - | - | 2.76M | 0.30M |
Total liab | 99.73M | 112.71M | 94.21M | 58.09M | 31.34M |
Total stockholder equity | 131.56M | 156.35M | 147.21M | 10.17M | 9.59M |
Deferred long term liab | - | - | - | - | - |
Other current liab | 3.67M | 6.34M | 9.98M | 2.46M | 2.12M |
Common stock | - | 279.51M | 208.90M | 32.55M | 26.28M |
Capital stock | 288.03M | 279.51M | 208.90M | 32.55M | 26.28M |
Retained earnings | -205.93400M | -168.09300M | -87.79200M | -34.35900M | -26.69600M |
Other liab | - | 9.60M | 8.58M | 2.19M | 0.81M |
Good will | 76.20M | 83.42M | 79.95M | 6.06M | 4.13M |
Other assets | - | 3.19M | 4.91M | 3.00M | 3.45M |
Cash | 30.12M | 25.08M | 14.01M | 7.52M | 0.81M |
Cash and equivalents | - | - | - | - | - |
Total current liabilities | 58.14M | 59.94M | 40.79M | 27.46M | 10.80M |
Current deferred revenue | - | - | - | - | - |
Net debt | 7.37M | 11.03M | 11.64M | 22.77M | 23.19M |
Short term debt | - | - | - | - | - |
Short long term debt | 24.98M | 19.09M | 6.55M | 16.39M | 4.27M |
Short long term debt total | - | - | - | - | - |
Other stockholder equity | - | 21.88M | 10.94M | 7.27M | 7.88M |
Property plant equipment | - | 62.00M | 52.74M | 29.50M | 12.38M |
Total current assets | 68.64M | 64.06M | 46.29M | 19.28M | 12.74M |
Long term investments | 0.18M | 0.20M | 0.51M | 1.72M | - |
Net tangible assets | - | 10.86M | 4.93M | -7.85600M | -2.58800M |
Short term investments | 0.14M | 0.20M | 0.86M | 0.05M | 0.05M |
Net receivables | 7.47M | 8.20M | 7.45M | 2.94M | 2.65M |
Long term debt | 12.51M | 17.03M | 19.11M | 13.91M | 19.73M |
Inventory | 25.97M | 23.41M | 17.04M | 8.46M | 7.10M |
Accounts payable | 8.35M | 26.89M | 18.53M | 6.42M | 4.41M |
Total permanent equity | - | - | - | - | - |
Noncontrolling interest in consolidated entity | - | - | - | - | - |
Temporary equity redeemable noncontrolling interests | - | - | - | - | - |
Accumulated other comprehensive income | - | - | - | - | - |
Additional paid in capital | - | - | - | - | - |
Common stock total equity | - | - | - | - | - |
Preferred stock total equity | - | - | - | - | - |
Retained earnings total equity | - | - | - | - | - |
Treasury stock | - | - | - | - | - |
Accumulated amortization | - | - | - | - | - |
Non currrent assets other | - | - | - | - | - |
Deferred long term asset charges | - | - | - | - | - |
Non current assets total | 164.76M | 210.68M | 199.93M | 50.53M | 28.00M |
Capital lease obligations | 35.04M | 33.77M | 29.77M | 16.67M | 0.02M |
Long term debt total | - | - | - | - | - |
Breakdown | 2022-10-31 | 2021-10-31 | 2020-10-31 | 2019-10-31 | 2018-10-31 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2022-10-31 | 2021-10-31 | 2020-10-31 | 2019-10-31 | 2018-10-31 |
Investments | -8.59200M | -0.50700M | 1.70M | 1.70M | 1.70M |
Change to liabilities | 1.84M | 0.90M | 2.47M | 2.84M | 1.72M |
Total cashflows from investing activities | -8.59200M | -28.49300M | -3.30300M | -16.92200M | -4.22700M |
Net borrowings | -1.89800M | -10.07600M | 3.69M | 24.88M | 0.54M |
Total cash from financing activities | 15.17M | 37.81M | 1.17M | 24.01M | 20.14M |
Change to operating activities | -2.84800M | -3.66800M | 1.23M | 3.12M | -5.99800M |
Net income | -71.75600M | -34.35700M | -6.35400M | -26.29200M | -4.53300M |
Change in cash | 11.07M | 6.49M | 6.72M | -7.39200M | 7.13M |
Begin period cash flow | 14.01M | 7.52M | 0.81M | 8.20M | 1.07M |
End period cash flow | 25.08M | 14.01M | 7.52M | 0.81M | 8.20M |
Total cash from operating activities | 4.50M | -2.82500M | 8.85M | -14.48200M | -8.77900M |
Issuance of capital stock | 19.45M | 38.57M | - | 0.00000M | 3.89M |
Depreciation | 30.14M | 24.54M | 7.33M | 1.29M | 0.08M |
Other cashflows from investing activities | - | - | - | - | - |
Dividends paid | 0.00000M | 0.00000M | 0.00000M | 0.00000M | 1.16M |
Change to inventory | -2.86500M | -5.50100M | 1.95M | -1.81100M | -0.10200M |
Change to account receivables | -0.73800M | -1.62900M | -0.45800M | -1.92000M | -0.67300M |
Sale purchase of stock | - | - | - | - | - |
Other cashflows from financing activities | -4.83600M | -8.05900M | -2.52000M | -0.87200M | 16.87M |
Change to netincome | 48.31M | 15.68M | 2.18M | 8.21M | 0.73M |
Capital expenditures | 7.76M | 10.56M | 2.29M | 8.07M | 3.58M |
Change receivables | - | - | - | - | - |
Cash flows other operating | - | - | - | - | - |
Exchange rate changes | - | - | - | - | - |
Cash and cash equivalents changes | - | - | - | - | - |
Change in working capital | -4.61200M | -9.89700M | 5.20M | 1.85M | -5.05671M |
Stock based compensation | 8.08M | 4.88M | 0.13M | 2.21M | - |
Other non cash items | 5.28M | 6.30M | 5.94M | 1.48M | 0.00771M |
Free cash flow | -4.56000M | -13.53800M | 6.08M | -25.24000M | -13.00612M |
Sector: Healthcare Industry: Pharmaceutical Retailers
Company | Change (CAD) | Price (CAD) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | Enterprise Value to EBITDA (x) |
---|---|---|---|---|---|---|---|---|
HITI High Tide Inc |
0.07 2.16% | 3.31 | - | 95.24 | 0.60 | 2.11 | 0.66 | 78.12 |
High Tide Inc. engages in the cannabis retail business in Canada, the United States, and internationally. The company operates through Retail and Wholesale segments. It operates licensed retail cannabis stores; and provides data analytics services. In addition, the company manufactures and distributes consumption accessories. Further, it sells its products through online sales via e-commerce platform. The company offers its products under the Daily High Club, DankStop, FABCBD, GC, Nuleaf, Smoke Cartel, and Blessed CBD brands. The company was formerly known as High Tide Ventures Inc. and changed its name to High Tide Inc. in October 2018. High Tide Inc. was founded in 2009 and is headquartered in Calgary, Canada.
11127 - 15 Street N.E., Calgary, AB, Canada, T3K 2M4
Name | Title | Year Born |
---|---|---|
Mr. Harkirat Grover | Founder, CEO, Pres & Exec. Chairman | 1982 |
Mr. Rahim Kanji C.A., CPA, M.B.A. | Chief Financial Officer | NA |
Mr. Aman Sood | Chief Operating Officer | NA |
Mr. Andreas-Alexander Palalas | Chief Revenue Officer | 1991 |
Ms. Joy Lisa Avzar | VP & Legal Counsel | NA |
Mr. Omar Khan | Sr. VP of Corp. & Public Affairs | NA |
Ms. Sandy Sharma | Sr. Director of HR | NA |
Mr. Shimshon Posen J.D. | Sec. & Treasurer | NA |
Mr. Harkirat Grover | Founder, CEO, President & Executive Chairman | 1982 |
Mr. Omar Yar Khan | Chief Communications & Public Affairs Officer | NA |
Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.